Literature DB >> 18343803

Polyene susceptibility is dependent on nitrogen source in the opportunistic pathogen Candida albicans.

Brian G Oliver1, Peter M Silver, Theodore C White.   

Abstract

OBJECTIVES: Polyene antifungal drugs, including amphotericin B or nystatin, target ergosterol in the fungal plasma membrane and are used to treat systemic, vaginal and oral fungal infections. In the oral cavity, the available nitrogen sources are primarily in the form of proteins, which are poor nitrogen sources. This study evaluates the effect of protein as a nitrogen source on drug susceptibilities.
METHODS: Candida albicans was grown in protein [bovine serum albumin (BSA) or casein (CSN)] as a sole nitrogen source, in ammonium sulphate (AS) as a nitrogen source, or in both protein and AS.
RESULTS: Cells grown in BSA or CSN were 4- to 16-fold less susceptible to amphotericin B and nystatin than those grown in AS. Similar results were observed for cycloheximide, but not for fluconazole or caspofungin, and were observed for many C. albicans clinical isolates. The results were observed in two different media, and in broth and on agar. Cells grown under these nitrogen-poor conditions have a reduction in ergosterol sterol levels and a reduction in overall sterol synthesis. Quantitative real-time reverse transcription-polymerase chain reaction analysis shows that some genes involved in sterol biosynthesis are induced under nitrogen-limiting conditions, consistent with the lower sterol levels.
CONCLUSIONS: The results demonstrate that nitrogen source has a significant effect on polyene susceptibilities. As these nitrogen-limiting conditions mimic oral nitrogen availability, they suggest that in vitro polyene susceptibilities may overestimate the in vivo susceptibilities to polyene drugs in the mouth.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18343803      PMCID: PMC2424025          DOI: 10.1093/jac/dkn101

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  26 in total

Review 1.  Systemic fungal infections: diagnosis and treatment. I. Therapeutic agents.

Authors:  J R Graybill
Journal:  Infect Dis Clin North Am       Date:  1988-12       Impact factor: 5.982

Review 2.  Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997.

Authors:  M M McNeil; S L Nash; R A Hajjeh; M A Phelan; L A Conn; B D Plikaytis; D W Warnock
Journal:  Clin Infect Dis       Date:  2001-07-30       Impact factor: 9.079

3.  Resistance mechanisms in clinical isolates of Candida albicans.

Authors:  Theodore C White; Scott Holleman; Francis Dy; Laurence F Mirels; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

4.  Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis.

Authors:  F De Bernardis; L Agatensi; I K Ross; G W Emerson; R Lorenzini; P A Sullivan; A Cassone
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

5.  Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae.

Authors:  Laura Y Young; Christina M Hull; Joseph Heitman
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

Review 6.  Candida albicans secreted aspartyl proteinases in virulence and pathogenesis.

Authors:  Julian R Naglik; Stephen J Challacombe; Bernhard Hube
Journal:  Microbiol Mol Biol Rev       Date:  2003-09       Impact factor: 11.056

7.  Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents.

Authors:  Dominique Sanglard; Françoise Ischer; Tania Parkinson; Derek Falconer; Jacques Bille
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

8.  Tetracycline alters drug susceptibility in Candida albicans and other pathogenic fungi.

Authors:  Brian G Oliver; Peter M Silver; Chelsea Marie; Samantha J Hoot; Sarah E Leyde; Theodore C White
Journal:  Microbiology       Date:  2008-03       Impact factor: 2.777

9.  Nitrogen metabolism and virulence of Candida albicans require the GATA-type transcriptional activator encoded by GAT1.

Authors:  Thawornchai Limjindaporn; Roy A Khalaf; William A Fonzi
Journal:  Mol Microbiol       Date:  2003-11       Impact factor: 3.501

10.  The Candida albicans lanosterol 14-alpha-demethylase (ERG11) gene promoter is maximally induced after prolonged growth with antifungal drugs.

Authors:  Jia L Song; Jo Beth Harry; Richard T Eastman; Brian G Oliver; Theodore C White
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

View more
  1 in total

1.  Aspergillus terreus and the Interplay with Amphotericin B: from Resistance to Tolerance?

Authors:  Roya Vahedi-Shahandashti; Anna-Maria Dietl; Ulrike Binder; Markus Nagl; Reinhard Würzner; Cornelia Lass-Flörl
Journal:  Antimicrob Agents Chemother       Date:  2022-03-07       Impact factor: 5.938

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.